Local Ablation Procedures in Primary Liver Tumors: Levovist US Versus Spiral CTto Evaluate Therapeutic Results

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5075-5079

  Vallone, Paolo ^a,b   Gallipoli, Adolfo ^a   Izzo, Francesco ^a   Fiore, Francesco ^a   Delrio, Paolo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Doppler ultrasound; Hepatocellular carcinoma; Spiral computed tomography; Ultrasound contrast media

Indexed keywords

IODINATED CONTRAST MEDIUM; SHU 508;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CATHETER ABLATION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LIVER CELL CARCINOMA; LOW LEVEL LASER THERAPY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; ETHANOL; FEMALE; HUMANS; LASERS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYSACCHARIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0842343491     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kratzer W, Kachele V, Merkle E, Mason R, Buchner M, von Tirpitz C and Pfeiffer M: Contrast enhanced power-Doppler sonography: comparison of various administration forms of the ultrasound contrast agent Levovist. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb-Verfahr 172(5): 443-8, 2000.
2. Kimura M, Sato M, Shioyama Y, Hagihira T, Horihata K, Terada M, Kishi K, Tanaka K and Kawai N: Therapeutic effect of TAE in patients with hepatocellular carcinoma using color-Doppler imaging with intravenous ultrasound contrast agent. Nippon igaku Hoshasen Gakkai Zasshi 60(6): 320-3, 2000.
3. Correas J, Claudon M, Lefevre F, Helenon O, Cattin F and Vilgrain V: Ultrasound contrast agents. J Radiol 81(4):423-33, 2000.
4. Hosoki T, Yosioka Y, Matsubara T, Minamitani K, Higashi M, Ohtani M, Choi S, Mitomo M and Tono T: Power-Doppler sonography of hepatocellular carcinoma treated by transcatheteral arterial chemoembilization. Assessment of the therapeutic effects. Acta Radiol 40(6): 639-43, 1999.
5. Catalano O, Esposito M, Lobianco R, Cusati B, Altei F and Siani A: Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced Doppler ultrasonography. Cardiovasc Intervent Radiol 22(6): 486-92, 1999.
6. Goldberg SN, Walovitch RC, Straub JA, Shore MT and Gazelle GS: Radiofrequency-induced coagulation necrosis in rabbits: immediate detection at US with systemic microsphere contrast agent. Radiology 213(2): 438-44, 1999.
7. Pennisi F, Farina F, Ponzio R, Fragione D, Lombardo R, Azzarello G and Puleo S: Role of color-Doppler ultrasonography with contrast media in the monitoring of hepatocarcinoma after intralesional treatment. Radiologia Medica 97(3):144-7, 1999.
8. Bartolozzi C, Lencioni R, Ricci P, Paolicchi, A, Rossi P and Passariello R: Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color-Doppler US. Radiology 209(2): 387-93, 1998.